How is the Timed Get‑Up‑and‑Go test scored and interpreted, including normal and abnormal values?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Timed Up and Go (TUG) Test Scoring and Interpretation

The TUG test is scored by timing the patient as they stand from a chair, walk 3 meters, turn around, walk back, and sit down, with a time greater than 12 seconds indicating abnormal performance and increased fall risk. 1

How to Perform and Score the Test

The test is straightforward:

  • Instruct the patient to rise from a standard chair (with armrests)
  • Walk 3 meters (approximately 10 feet) at their normal pace
  • Turn around completely
  • Walk back to the chair
  • Sit down

Record the total time in seconds from the moment they start to stand until they are fully seated again. 1

Normal vs. Abnormal Values

Primary Clinical Cutoff

A time >12 seconds is abnormal and indicates increased fall risk, requiring broader fall risk assessment and intervention 1. This threshold should trigger:

  • Comprehensive fall risk evaluation
  • Physical therapy referral for exercise programming and walking aid assessment
  • Assessment of P-SCHEME factors (Pain, Shoes, Cognitive impairment, Hypotension, Eyesight, Medications, Environmental factors) 1

Age-Stratified Reference Values

For community-dwelling older adults without gait disturbances:

  • 60-69 years: 8.1 seconds (normal range: 7.1-9.0 seconds) 2
  • 70-79 years: 9.2 seconds (normal range: 8.2-10.2 seconds) 2
  • 80-99 years: 11.3 seconds (normal range: 10.0-12.7 seconds) 2

Community-dwelling women aged 65-85 should complete the test in ≤12 seconds, with 92% of healthy community-dwelling women achieving this benchmark 3. Times exceeding 20 seconds indicate severely impaired mobility, as all healthy community-dwelling women completed the test below this threshold 3.

Institutional vs. Community Context

The interpretation differs dramatically by setting:

  • Community-dwelling: Only 8% have times >12 seconds 3
  • Institutionalized: 91% have times >12 seconds, with 26% exceeding 30 seconds 3

This highlights that residential and mobility status are the strongest predictors of TUG performance, explaining 54% of test variation 3.

Factors Affecting Performance

Slower times are associated with:

  • Advanced age (correlation r=0.25) 4
  • Female sex (women average 1.9 seconds slower than men) 4
  • Lower body weight and height 4
  • Poor nutritional status 4
  • Cognitive impairment 4
  • Lower socioeconomic status 5
  • Higher body mass index 5
  • Multiple medical comorbidities 5
  • Worse perceived physical and mental health 5

Clinical Application Algorithm

When TUG >12 seconds:

  1. Conduct comprehensive fall risk assessment
  2. Evaluate P-SCHEME factors systematically
  3. Refer to physical therapy for:
    • Individualized exercise program (tai chi, walking, resistance training)
    • Walking aid evaluation
  4. Address modifiable risk factors over multiple visits 1

When TUG ≤12 seconds but patient answers "yes" to any of these three questions:

  • Have you fallen in the past year?
  • Do you feel unsteady when standing or walking?
  • Are you worried about falling?

Still proceed with fall risk assessment, as positive screening on these questions warrants intervention regardless of TUG time 1.

Important Caveats

  • The test requires the patient to be ambulatory; those unable to perform it represent a high-risk group requiring immediate intervention 4
  • Exclude patients with obvious gait disturbances from normative comparisons, as they represent a different clinical population 4
  • The 12-second cutoff is specifically validated for fall risk screening in older adults; younger populations have different reference ranges (mean 9.16 seconds for ages 21-85) 6
  • Performance improves with practice, so consider allowing one practice trial before recording the official time 7

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
In kidney transplant recipients on standard immunosuppressants (tacrolimus, cyclosporine, mycophenolate mofetil, azathioprine, prednisone, sirolimus, everolimus), how safe are antiviral agents such as entecavir or tenofovir (including tenofovir alafenamide) regarding drug interactions and the need for dose adjustments?
What treatments for post‑inflammatory hyperpigmentation are available in the Philippines?
How should a patient with an INR of 2.08 be prepared for surgery?
What is the appropriate titration schedule for duloxetine tablets?
What is the recommended titration schedule for duloxetine (Cymbalta) in the treatment of neuropathic pain, including dose adjustments for patients with hepatic impairment or elderly patients?
Can a topical formulation containing 5% niacinamide, double‑strength vitamin C, tranexamic acid, and hyaluronic acid be used to treat post‑inflammatory hyperpigmentation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.